Immix Biopharma, Inc. · Brief

Next report

10 days

Nov 10est.Q3 FY26

Expected move

±15.8%implied · straddle

6.478.89

spot 7.68exp Nov 20ATM strike 7.5ATM straddle 1.43IV 98%

Oct 30 close

Expected move

No reported quarters.

Nov 10 report · est.

Bull2 of 3

+100.12%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

2 of 19of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

Bear2

0.20%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

17managers whose positions together make up four fifths of the reported value13F · Jun 30 '26

AI captions · Sep 16 '26once per report · top 2 per case

IMMX report session

No linked exposure.

Oct 27impliedImplied move: ±27.5% into Nov 10 earnings (Oct 27 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.